Systemic Th1 Immunization of Mice againstHelicobacter pyloriInfection with CpG Oligodeoxynucleotides as Adjuvants Does Not Protect from Infection but Enhances Gastritis

Frank Sommer, H Wilken, Gerhard Faller, Michael LohoffInfection 2004 · DOI

Abstract

Recent reports have suggested that oral vaccination of mice against Helicobacter pylori is dependent on a Th1-mediated immune response. However, oral vaccination in mice neither induces sterilizing immunity nor leads to complete protection from disease. Therefore, in this study we investigated whether a systemic subcutaneous immunization against H. pylori by using CpG oligodeoxynucleotides as a Th1 adjuvant could achieve protection in a mouse model of H. pylori infection. CpG oligodeoxynucleotides are known for their ability to induce nearly entirely Th1-biased immune responses and may be approved for human use in future. Immunization of mice with H. pylori lysate and CpG induced a strong local and systemic Th1 immune response. Despite this strong Th1 response, mice were not protected from infection with H. pylori yet had a 10-fold reduction in the number of H. pylori in the gastric mucosa compared to nonimmunized mice. Of note, reduction of the bacterial density in immunized mice was accompanied by a significantly enhanced gastritis. Hence, systemic Th1 immunization of mice, even though being able to reduce the bacterial load in the stomach, is associated with aggravated pathology.
BibTeX
@inproceedings{sommer2004systemic,
  author = {Frank Sommer and H Wilken and Gerhard Faller and Michael Lohoff},
  title = {{Systemic Th1 Immunization of Mice against<i>Helicobacter pylori</i>Infection with CpG Oligodeoxynucleotides as Adjuvants Does Not Protect from Infection but Enhances Gastritis}},
  booktitle = {Infection},
  year = {2004},
  doi = {10.1128/iai.72.2.1029-1035.2004},
}

Loading related content...

Figure